Hello,
Here are (belated) minutes of last Thursday's TC. The next call
will be in November 22nd at 2pm CET.
- First, the most important point: The few remaining analysis
results and methods text need to be sent to Tuuli
without
delay. The deadline was weeks ago, and now we can't wait any
longer - I have already drafted the main paper.
- We got very good feedback at the Geuvadis annual meeting in
Santiago de Compostela. A couple of important decisions regarding
the RNAseq WP were made:
- we decided to make a pre-publication data release of fastqs
and bams, so the files are now out there, esiset access is through
www.geuvadis.org. This was announced at the 1000 Genomes meeting,
advertised in San Francisco in general, and now also mentioned in
the 1000G website. The data is under embargo until publication of
the main paper.
- we discussed the author list - the latest version for the
main paper can be seen under the data link. In addition to the ~60
named authors, there will be a "the Geuvadis consortium" listed
before the PIs, and acknowledgements will include e.g.
technicians. In the companions and subsequent papers, the people
involved in that particular analyses should be named, and "the
Geuvadis consortium" author will contain all the authors of the
main paper, indexed and visible to PubMed.
- people thought that making the wiki open to the public when
the paper comes out is a good idea
- there was discussion on future RNAseq experiments but no
definite decisions on this
- At the ASHG meeting in SF people were in general very interested
and impressed by our work. We discussed with editors of Nature and
Science and both were interested in the paper; our first target
will be Nature as discussed before. However, there is competition:
a group from Stanford will be submitting a major RNAseq paper in
the end of November, and while they don't have genome sequencing
data and the analyses are not too badly overlapping, we really
need to hurry up now so that their paper is not accepted before we
submit.
- The main paper outline was discussed. Due to the competition
situation, we need to submit by December 15, which is doable if we
work hard. Tuuli has finished writing the first draft of the main
paper text; this will be sent around soon. As mentioned above, any
pending analyses need to be finished right now or they are very
unlikely to make it to the paper. We are putting together the
Supplement now but still missing methods text from 1-2 of you.
Please send it to me without delay.
- We discussed the outline of the splicing paper. We should be
able to submit that at the same time with the main paper.
best regards,
Tuuli
Tuuli Lappalainen, PhD
Department of Genetic Medicine and Development
University of Geneva Medical School
CMU / Rue Michel-Servet 1
1211 Geneva 4
Switzerland
Tel. +41-(0)22-3795550
tuuli.lappalainen@unige.ch
On /15/1112 5:54 AM, Tuuli Lappalainen wrote: